We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2021 16:34 | It's my opinion that the only reason for the upmove is Kights continued buying. He will definitely be the largest single shareholder after this latest purchase, his reasons are still a mystery, but will it keep going up ? No, as soon as he is done this will drift back down to around 5.25p. Im not discounting the chance that he could make an outright bid for the company, but it won't be any higher then 8.25p. | kingalf | |
25/8/2021 13:53 | Heading back to the 8p placing price by the looks of it, with c£12m plus cash in the bank and a multiple disease pipeline, ridiculously undervalued compared to other similar clinical stage Bio's worth several £100m. Gla:-) | moneymunch | |
25/8/2021 13:51 | Hats off to AlanCapone !!! | mesquida | |
25/8/2021 13:38 | Looking good and strong, don't you think Kingalf??? :-))) | moneymunch | |
25/8/2021 09:34 | They will take 1 million at 5.95 ! | amaretto1 | |
25/8/2021 09:04 | Gone to NT to buy over a £grand or two; positive sign. Plus couldn't sell first thing. Now can get quote, no problem. Seem to be in demand | davethechef | |
25/8/2021 06:58 | Lol kingalf, don't push it mate if you're incapable of having a balanced view. ;-) | moneymunch | |
24/8/2021 21:20 | KingArsie, increases in share prices often relate to people buying them. Just saying! | bocker01 | |
24/8/2021 20:28 | AlanCapone - Me thinks your trying to ramp this up, your technical analysis projection is total fantasy, don't get sucked in by this low life. As has been the case over the last month or so, Kight adding to his position is behind the current move up. This will be confirmed in the next day or so. | kingalf | |
24/8/2021 15:46 | Wonder if he's related to 'profkevin' on the other thread, who announced he'd sold out at 5p last week? | on target | |
24/8/2021 15:37 | Don't try reasoning with that brain donor MM. | alancapone | |
24/8/2021 15:34 | Where's the pump??? Evgen is completely undervalued commensurate to the c£12m cash in the bank and multiple disease pipeline compared to similar stage Bio's, many valued at several £100m.....Gla holders....good news approaching??? ;-) | moneymunch | |
24/8/2021 15:14 | Pump and dump operation in full flown | kevinroe | |
24/8/2021 14:27 | happy to be educated, give me some pointers please ...and of course would be well pleased to see 34-40! must be that man with the printers at it again | jusjusjus | |
24/8/2021 14:21 | These are above normal trade sizes today !! | amaretto1 | |
24/8/2021 14:15 | Maybe some technical analysis education would be in order then? | alancapone | |
24/8/2021 14:11 | struggling to see where 34-40 could come from on that chart? | jusjusjus | |
24/8/2021 13:56 | These are purely technical analysis driven targets from a automatic tool (removes any cognitive bias). They produce spookily accurate results. | alancapone | |
24/8/2021 13:42 | Is that your target Alan, 34 - 40 ? And over what sort of time scale ? | mesquida | |
24/8/2021 13:29 | EVG hitting the third wave now. Back with a target in 2 mins. | alancapone | |
24/8/2021 13:10 | EVG moving again !! | dutch123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions